BMEDvsXLVETF Comparison
VS
iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. BMED's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, XLV's top sector exposures are Healthcare and Consumer Non-Cyclicals. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.08% for XLV. BMED is up 1.48% year-to-date (YTD) with +$4M in YTD flows. XLV performs better with 4.97% YTD performance, and +$608M in YTD flows. Run a side-by-side ETF comparison of BMED and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BMED vs XLV performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/17/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BMED XLV | +7.90%+7.36% | +4.20%+8.75% | +1.48%+4.97% | +23.30%+23.57% | +23.27%+29.18% | +4.16%+37.28% |
| Flows | BMED XLV | -+$645M | --$388M | +$4M+$608M | +$6M+$2.22B | +$4M-$5.78B | +$5M+$3.71B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BMED XLV | +17.48%+18.38% | +15.99%+15.83% | +16.00%+14.32% | +17.71%+14.96% |
| Max drawdown | BMED XLV | -7.61%-4.03% | -14.71%-10.51% | -19.76%-17.05% | -33.96%-17.05% |
| Max drawdown duration | BMED XLV | 65d32d | 176d116d | 237d444d | 1586d444d |
Trading data
BMED | XLV | |
Last sale 7/17/2026 at 1:30 PM | $30.65 | $161.09 |
| Previous close 07/16/2026 | $30.80 | $161.80 |
| Consolidated volume 07/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of June 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BMED
is actively managed and doesn’t replicate an indexBMED | XLV | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/17/2026 at 1:30 PM
Live
Closed
BMED | XLV | |
|---|---|---|
| Last price | $30.65 | $161.09 |
| 1D performance | -0.49% | -0.44% |
| AuM | $11.03 M | $41.81 B |
| E/R | 0.77% | 0.08% |
Characteristics
BMED | XLV | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | iShares | State Street Investment Management |
| Benchmark | - | S&P Health Care Select Sector Index |
| N° of holdings | 51 | 59 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 29, 2020 | December 16, 1998 |
| ESG | No | No |
Advertisement
Exposure
Countries
BMED
USA
83.2%
Other
16.8%
XLV
USA
97.58%
Other
2.42%
Sectors
BMED
Healthcare
94.88%
Other
5.12%
XLV
Healthcare
97.58%
Other
2.42%
Advertisement
Diversification
BMED
Total weight of top 15 holdings out of 15
57.26%
XLV
Total weight of top 15 holdings out of 15
71.84%
Top 15 holdings
Data as of May 31, 2026
BMED
Gilead Sciences, Inc.
5.42%
Merck & Co., Inc.
5.17%
Johnson & Johnson
5.15%
Edwards Lifesciences Corp.
4.79%
BlackRock Cash Funds - Treasury
4.74%
Waters Corp.
3.84%
Biogen, Inc.
3.67%
Bruker Corp.
3.64%
Amgen, Inc.
3.41%
WuXi Biologics (Cayman), Inc.
3.13%
Charles River Laboratories International, Inc.
3.12%
Vertex Pharmaceuticals, Inc.
2.99%
Mettler-Toledo International, Inc.
2.80%
Danaher Corp.
2.77%
Moderna, Inc.
2.65%
XLV
Eli Lilly & Co.
16.19%
Johnson & Johnson
10.04%
AbbVie, Inc.
7.12%
UnitedHealth Group, Inc.
6.37%
Merck & Co., Inc.
5.45%
Thermo Fisher Scientific, Inc.
3.42%
Amgen, Inc.
3.35%
Gilead Sciences, Inc.
3.08%
Intuitive Surgical, Inc.
2.79%
Pfizer Inc.
2.75%
Abbott Laboratories
2.75%
Bristol Myers Squibb Co.
2.15%
CVS Health Corp.
2.14%
Danaher Corp.
2.13%
Vertex Pharmaceuticals, Inc.
2.10%
Frequently asked questions about BMED and XLV
How have the BMED and XLV ETFs performed in 2026?
As of July 17, 2026, BMED is up 1.48% year-to-date (YTD), while XLV has returned 4.97%. That puts XLV better performer ahead so far this year.
Which ETF is attracting more investor money: BMED or XLV?
Year-to-date, the BMED ETF saw +$4M in flows, compared to +$608M for XLV.
Which ETF is more volatile: BMED or XLV?
Over the past year, BMED had a volatility of 15.99%, while XLV experienced 15.83%.
Which ETF is bigger: BMED or XLV?
As of July 17, 2026, BMED holds $11.03 M in assets under management (AUM), while XLV manages $41.81 B.
What sectors do the BMED and XLV ETFs invest in?
BMED leans toward sectors like Healthcare. Meanwhile, XLV focuses on Healthcare.
What are the top holdings of the BMED ETF and XLV ETF?
BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and Johnson & Johnson. XLV holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
Which ETF is more diversified: BMED or XLV?
BMED holds 54 securities with 57.26% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 71.84%.
Advertisement
Latest news about BMED & XLV
ETF Model Portfolios: The Cockroach Portfolio
March 20, 2026
XLV
ETF Central's Guide to Defensive Sector Investing
March 13, 2026
XLV
Chinese Artificial Intelligence (AI) DeepSeek: ETF Winners & Losers
January 27, 2025
XLV
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities
August 21, 2024
XLV
Advertisement
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Healthcare Stocks Drop on Medicare Payment Rate Surprise
April 8, 2024
XLV
Advertisement
